Evidence map›Paper›PMID 37309288›Full record

ArticleCNS neuroscience & therapeutics2023

Medial prefrontal cortical PPM1F alters depression-related behaviors by modifying p300 activity via the AMPK signaling pathway.

Jing Liu, Fantao Meng, Wentao Wang, Min Wu, Yu Zhang, Minghu Cui, Changyun Qiu, Fengai Hu, Di Zhao, Dan Wang and 6 more

Open access · goldAbstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Dorsal raphe dopaminergic neurons target CaMKIITranslational psychiatry · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Jing LiuDepartment of Rehabilitation Medicine, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Fantao MengDepartment of Rehabilitation Medicine, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Wentao WangDepartment of Rehabilitation Medicine, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Min WuMedical Research Center, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Yu ZhangMedical Research Center, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Minghu CuiMedical Research Center, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Changyun QiuMedical Research Center, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Fengai HuMedical Research Center, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Di ZhaoDepartment of Rehabilitation Medicine, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Dan WangDepartment of Rehabilitation Medicine, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Cuilan LiuDepartment of Rehabilitation Medicine, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Dunjiang LiuMedical Research Center, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Zhicheng XuMedical Research Center, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Yameng WangMedical Research Center, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Wei LiDepartment of Rehabilitation Medicine, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Chen LiDepartment of Rehabilitation Medicine, Binzhou Medical University Hospital, Binzhou, Shandong, China.ORCID 0000-0001-5385-6249
Binzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsProtein phosphatase Mg2+/Mn2+-dependent 1F (PPM1F) is a serine/threonine phosphatase, and its dysfunction in depression in the hippocampal dentate gyrus has been previously identified. Nevertheless, its role in depression of another critical emotion-controlling brain region, the medial prefrontal cortex (mPFC), remains unclear. We explored the functional relevance of PPM1F in the pathogenesis of depression.

methodsThe gene expression levels and colocalization of PPM1F in the mPFC of depressed mice were measured by real-time PCR, western blot and immunohistochemistry. An adeno-associated virus strategy was applied to determine the impact of knockdown or overexpression of PPM1F in the excitatory neurons on depression-related behaviors under basal and stress conditions in both male and female mice. The neuronal excitability, expression of p300 and AMPK phosphorylation levels in the mPFC after knockdown of PPM1F were measured by electrophysiological recordings, real-time PCR and western blot. The depression-related behavior induced by PPM1F knockdown after AMPKα2 knockout or the antidepressant activity of PPM1F overexpression after inhibiting acetylation activity of p300 was evaluated.

resultsOur results indicate that the expression levels of PPM1F were largely decreased in the mPFC of mice exposed to chronic unpredictable stress (CUS). Behavioral alterations relevant to depression emerged with short hairpin RNA (shRNA)-mediated genetic knockdown of PPM1F in the mPFC, while overexpression of PPM1F produced antidepressant activity and ameliorated behavioral responses to stress in CUS-exposed mice. Molecularly, PPM1F knockdown decreased the excitability of pyramidal neurons in the mPFC, and restoring this low excitability decreased the depression-related behaviors induced by PPM1F knockdown. PPM1F knockdown reduced the expression of CREB-binding protein (CBP)/E1A-associated protein (p300), a histone acetyltransferase (HAT), and induced hyperphosphorylation of AMPK, resulting in microglial activation and upregulation of proinflammatory cytokines. Conditional knockout of AMPK revealed an antidepressant phenotype, which can also block depression-related behaviors induced by PPM1F knockdown. Furthermore, inhibiting the acetylase activity of p300 abolished the beneficial effects of PPM1F elevation on CUS-induced depressive behaviors.

conclusionOur findings demonstrate that PPM1F in the mPFC modulates depression-related behavioral responses by regulating the function of p300 via the AMPK signaling pathway.

Indexed as

AMP-Activated Protein KinasesPrefrontal CortexAnimalsAntidepressive AgentsDisease Models, AnimalE1A-Associated p300 ProteinFemaleMaleMicePhosphoprotein PhosphatasesRNA, Small InterferingSignal TransductionStress, PsychologicalAMP-Activated Protein KinasesAntidepressive AgentsE1A-Associated p300 ProteinEp300 protein, mousePhosphoprotein PhosphatasesPPM1F protein, mouseRNA, Small Interferingdepression-related behaviorsmPFCneuroinflammationneuronal excitabilityPPM1F-AMPK-p300 axis

Identifiers

PMID37309288
PMCPMC10580341
OpenAlexW4380421808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.